Skip to main content

Table 1 Chemotherapy and anti-EGFR monoclonal antibody (Mab) treatment

From: Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas

Chemotherapy P67.5 P70 Total
anti-EGFR Mab treatment anti-EGFR Mab treatment
+ - + -
None 3 11 20 19 53
ICT 2 2 0 4 8
CCRT 1 6 20 23 50
ACT 0 0 18 11 29
ICT + CCRT 29 32 0 8 69
CCRT + ACT 4 7 2 20 33
ICT + CCRT + ACT 13 36 0 0 49
ICT + ACT 2 0 3 0 5
Total 54 94 63 85 296
  1. Abbreviation: ICT induction chemotherapy, CCRT concurrent chemoradiotherapy, ACT adjuvant chemotherapy